VIP
Neurologic Manifestations
Danish Headache Centerprotein_peptideN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
35 Active assets in the Neurologic Manifestations cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Guanfacine Maimonides Medical Center | Phase 4 | BB |
Ginkgolide Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 4 | BB |
Guanfacine Maimonides Medical Center | Phase 4 | BB |
Opc-34712 Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 3 | BB |
Live Combined Bifidobacterium Beijing Friendship Hospital | Phase 4 | BB |
View all 50 →
Same molecule, other indications
VIP is also rated in:
Healthy Volunteers, Headache, Migraine, Hemodynamics, VIP, SPECT, UltrasoundDormant
D
Indicative ·
30 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →